RENOVORX, INC. (RNXT) Operating Margin
- Operating margin · 12 months: Value -685.22%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -685.22% | Operating income / revenue. Period ending 2026-06-30. $-13.54M ÷ $1.98M × 100 ≈ -685.22% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -13.54M USD | Operating Income (Loss) |
| Revenue | 1.98M USD | |
| Cost of products and services | (m) | |
| Research and development | 5.63M USD | Research and Development Expense |
| Selling, general and administration | 9.58M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-13.54M | $1.98M | (m) | $5.63M | $9.58M | -685.22% |
| 2026-03-31 | $-12.87M | $1.49M | (m) | $5.86M | $8.19M | -864.27% |
| 2025-12-31 | $-12.51M | $1.12M | (m) | $6.27M | $7.04M | -1113.98% |
| 2025-09-30 | $-11.62M | (m) | (m) | $6.34M | $5.91M | (m) |
| 2025-06-30 | $-11.25M | (m) | (m) | $6.29M | $5.37M | (m) |
| 2025-03-31 | $-11.60M | (m) | (m) | $6.41M | $5.34M | (m) |
| 2024-12-31 | $-10.97M | $43.00K | (m) | $6.03M | $4.99M | -25511.63% |
| 2024-09-30 | $-10.12M | (m) | (m) | $5.22M | (m) | (m) |
| 2024-06-30 | $-10.27M | (m) | (m) | $5.20M | (m) | (m) |
| 2024-03-31 | $-10.61M | (m) | (m) | $5.59M | (m) | (m) |
| 2023-12-31 | $-11.40M | (m) | (m) | $5.67M | (m) | (m) |
| 2023-09-30 | $-11.79M | (m) | (m) | $5.67M | (m) | (m) |
| 2023-06-30 | $-10.97M | (m) | (m) | $4.88M | (m) | (m) |
| 2023-03-31 | $-10.21M | (m) | (m) | $4.35M | (m) | (m) |
| 2022-12-31 | $-9.95M | (m) | (m) | $4.30M | (m) | (m) |
| 2022-09-30 | $-10.14M | (m) | (m) | $4.63M | (m) | (m) |
| 2022-06-30 | $-9.37M | (m) | (m) | $4.55M | (m) | (m) |
| 2022-03-31 | $-7.62M | (m) | (m) | $3.69M | (m) | (m) |
| 2021-12-31 | $-5.67M | (m) | (m) | $3.04M | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $-3.20M | (m) | (m) | $2.39M | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |